These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients. Jung K; Neumann R; Scholz D; Nugel E Clin Nephrol; 1982 Apr; 17(4):191-4. PubMed ID: 7042146 [TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein A-I and apolipoprotein B in survivors of myocardial infarction. Karira K; Baseer A J Pak Med Assoc; 1987 Feb; 37(2):44-7. PubMed ID: 3106663 [No Abstract] [Full Text] [Related]
27. Reduced high density lipoproteins as a risk factor after acute myocardial infarction. Franzén J; Johansson BW; Gustafson A Acta Med Scand; 1987; 221(4):357-62. PubMed ID: 3111177 [TBL] [Abstract][Full Text] [Related]
28. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E. Knopp RH; Walden CE; Warnick GR; Albers JJ; Ginsberg J; McGinnis BM Am J Med; 1987 Nov; 83(5B):75-84. PubMed ID: 3120587 [TBL] [Abstract][Full Text] [Related]
29. Anomalies in composition of uremic lipoproteins isolated by gradient ultracentrifugation: relative enrichment of HDL in apolipoprotein C-III at the expense of apolipoprotein A-I. Atger V; Duval F; Frommherz K; Drüeke T; Lacour B Atherosclerosis; 1988 Nov; 74(1-2):75-83. PubMed ID: 3145749 [TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)]. Haïat R; Bugugnani MJ Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931 [TBL] [Abstract][Full Text] [Related]
33. Factor analysis of plasma lipoprotein components. Aursnes I; Smith P; Christiansen EN; Berg K Atherosclerosis; 1988 Feb; 69(2-3):219-24. PubMed ID: 3126750 [TBL] [Abstract][Full Text] [Related]
34. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease. Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356 [TBL] [Abstract][Full Text] [Related]
35. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219 [TBL] [Abstract][Full Text] [Related]
36. Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia. Rosing U; Samsioe G; Olund A; Johansson B; Kallner A Horm Metab Res; 1989 Jul; 21(7):376-82. PubMed ID: 2506119 [TBL] [Abstract][Full Text] [Related]
37. Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men. Taskinen MR; Kuusi T; Yki-Järvinen H; Nikkilä EA J Clin Endocrinol Metab; 1988 Aug; 67(2):291-9. PubMed ID: 3134387 [TBL] [Abstract][Full Text] [Related]
38. Time-course of alterations of high density lipoproteins (HDL) during thyroxine administration to hypothyroid women. Verdugo C; Perrot L; Ponsin G; Valentin C; Berthezene F Eur J Clin Invest; 1987 Aug; 17(4):313-6. PubMed ID: 3117568 [TBL] [Abstract][Full Text] [Related]
39. Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism. De Bruin TW; Brouwer CB; Gimpel JA; Erkelens DW Am J Physiol; 1991 Mar; 260(3 Pt 1):E492-8. PubMed ID: 1900671 [TBL] [Abstract][Full Text] [Related]
40. Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. James RW; Pometta D Atherosclerosis; 1990 Jul; 83(1):35-45. PubMed ID: 2117929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]